PT - JOURNAL ARTICLE AU - Margherita Giorgini AU - Claudia Marchetti AU - Violante Di Donato AU - Jacopo Tesei AU - Natalina Manci AU - Pierluigi Benedetti Panici TI - Limits of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography in Recurrence Diagnosis of Borderline Ovarian Tumor AID - 10.1111/IGC.0b013e3181da2912 DP - 2010 Jun 01 TA - International Journal of Gynecologic Cancer PG - 694--697 VI - 20 IP - 5 4099 - http://ijgc.bmj.com/content/20/5/694.short 4100 - http://ijgc.bmj.com/content/20/5/694.full SO - Int J Gynecol Cancer2010 Jun 01; 20 AB - Most borderline ovarian tumors (BOT) occur in young women and exhibit a low malignant behavior. Nevertheless, an accurate long-term follow-up is required because, frequently, recurrence arises after many years from primary treatment, especially in patients affected by BOT with invasive peritoneal implants, which have a worse prognosis. We report the case of a pelvic recurrence of serous BOT firstly suspected by physical examination but misdiagnosed by 18F-fluorodeoxyglucose positron emission tomography and computed tomography and identified only by magnetic resonance imaging, 7 years after primary treatment. We also reviewed the literature concerning the role of 18F-fluorodeoxyglucose positron emission tomography in the management and follow-up of BOT.